A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05528510 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05528510
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2024-04-02
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.